By Justin Petrone

After securing a Health Canada license for its second-generation celiac-disease test, Toronto's SQI Diagnostics is now planning to submit the assay to US regulators and launch it in Europe later this year.

SQI's IgXPlex Celiac Panel, a quantitative 4-plex test that runs on the firm's automated SQiDworks diagnostics platform, received a Health Canada license, the firm announced last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.